Selecting plant genetics with high CO2
absorption and percentage of active
ingredients
We produce active plant ingredients in a
sustainable way
Reducing economic and environmental
costs with in vitro molecular biology
techniques
Capable of
Increasing x20 the amount of active
ingredients generated per square meter and
euro invested
Capable of
Enhancing the quality of raw material by
producing it under sterile conditions and
free of unwanted foreign matter
Capable of
Bringing sustainability back to the
pharmaceutical industry by reducing
x50 the use of H2O
x10 the amount of energy
x5 atmospheric CO2 emissions
Production of substances through
Innovative High-Tech
Technology
innovative
Propagating them through in vitro glandular
organogenesis, i.e., by growing only
substance-producing glands under sterile
conditions
Automating the process with sensorized
bioreactors which control and adapt the
growth conditions based on the needs of
the product
We grow in environmentally friendly phytotrons
Taking advantage of natural energy
resources (light, temperature, humidity).
Maximizing the use of the square meter by
being stackable with a beehive-like
structure
Using IoT and AI to prevent product contamination
Kanara is a clear example of where the industry should be heading, both in terms of narrative and product. A wave of innovation driven by startups with talented teams, striving to come up with innovative solutions that are less harmful to humans and more sustainable for the planet.
- Ángel Gutiérrez - CEO of Catalyst
